Lyra Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 332,320 | 0.508% |
Hedge Funds | 4,772,816 | 7.29% |
Institutions | 15,102,340 | 23.1% |
VC/PE Firms | 18,645,978 | 28.5% |
General Public | 26,604,194 | 40.6% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
12,757,562 | US$2.4m | 0% | 0.05% | |||
5,888,416 | US$1.1m | 0% | 2.18% | |||
4,772,816 | US$902.1k | 0% | no data | |||
2,993,626 | US$565.8k | 5.78% | no data | |||
2,780,261 | US$525.5k | 0% | 0.08% | |||
1,779,263 | US$336.3k | 2.79% | no data | |||
1,056,829 | US$199.7k | 0% | 0.06% | |||
997,782 | US$188.6k | 0% | no data | |||
768,388 | US$145.2k | 1.76% | no data | |||
512,482 | US$96.9k | -33.1% | no data | |||
488,720 | US$92.4k | 88.1% | no data | |||
460,300 | US$87.0k | -32.5% | no data | |||
451,789 | US$85.4k | 0% | no data | |||
282,547 | US$53.4k | -42.4% | no data | |||
261,966 | US$49.5k | 0% | no data | |||
252,708 | US$47.8k | 0% | 0.01% | |||
232,670 | US$44.0k | 0% | no data | |||
183,284 | US$34.6k | 119% | no data | |||
159,238 | US$30.1k | 0% | no data | |||
154,800 | US$29.3k | -59.6% | no data | |||
139,899 | US$26.4k | 207% | no data | |||
119,379 | US$22.6k | 0% | no data | |||
111,609 | US$21.1k | 0% | no data | |||
110,493 | US$20.9k | -88.8% | no data | |||
95,550 | US$18.1k | 292% | no data |